Jin-Long Chen
Director/Board Member chez TENAYA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Jin Long Chen was the founder of NGM Biopharmaceuticals, Inc. (founded in 2007) and TCG Labs-Soleil (founded in 2023), where he holds the titles of Director & Chief Scientific Officer and Managing Partner & CEO, respectively.
He is currently working as an Independent Director at Tenaya Therapeutics, Inc. since 2016.
In the past, he worked as Vice President-Research at Amgen, Inc. from 2004 to 2008 and as Vice President-Biology at Tularik, Inc. Dr. Chen holds a doctorate degree from the University of California, Berkeley, a graduate degree from National Taiwan University, and an undergraduate degree from Fu Jen Catholic University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2023 | 1 133 893 ( 1,36% ) | 2 M $ | 31/03/2024 | |
| 09/06/2023 | 25 000 ( 0,03% ) | 130 750 $ | 31/03/2024 |
Postes actifs de Jin-Long Chen
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Director/Board Member | 01/10/2016 |
Anciens postes connus de Jin-Long Chen
| Sociétés | Poste | Fin |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Founder | 04/04/2023 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Jin-Long Chen
| University of California, Berkeley | Doctorate Degree |
| National Taiwan University | Graduate Degree |
| Fu Jen Catholic University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
